Evidence map›Paper›PMID 26516165›Full record

ReviewToxicologic pathology2016

Meganucleases Revolutionize the Production of Genetically Engineered Pigs for the Study of Human Diseases.

Bethany K Redel, Randall S Prather

Open access · greenAbstract readReview
In one paragraph

Review in Toxicologic pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Treating genetic blood disorders in the era of CRISPR-mediated genome editing.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  3. Article
  4. Article
  5. Improvements in pig agriculture through gene editing.CABI agriculture and bioscience · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. CRISPR Editing in Biological and Biomedical Investigation.Journal of cellular biochemistry · 2017
    Review
  12. Review
  13. Review
  14. Engineering Large Animal Species to Model Human Diseases.Current protocols in human genetics · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Bethany K RedelDivision of Animal Science, University of Missouri, Columbia, Missouri, USA.
Randall S PratherDivision of Animal Science, University of Missouri, Columbia, Missouri, USA National Swine Resource and Research Center, University of Missouri, Columbia, Missouri, USA pratherr@missouri.edu.
University of Missouri · US

Funding

Resource Core for National Swine Resource and Research Center (NSRRC) Years 21-25U42OD011140 · OD · UNIVERSITY OF MISSOURI-COLUMBIA · PI RANDALL S PRATHER · 2012 to 2026
$26.7M
NIH HHS U42 OD011140NIH HHS U42OD011140-12
6 · The paper itself

Abstract

Animal models of human diseases are critically necessary for developing an in-depth knowledge of disease development and progression. In addition, animal models are vital to the development of potential treatments or even cures for human diseases. Pigs are exceptional models as their size, physiology, and genetics are closer to that of humans than rodents. In this review, we discuss the use of pigs in human translational research and the evolving technology that has increased the efficiency of genetically engineering pigs. With the emergence of the clustered, regularly interspaced, short palindromic repeat (CRISPR)/CRISPR-associated (Cas) protein 9 system technology, the cost and time it takes to genetically engineer pigs has markedly decreased. We will also discuss the use of another meganuclease, the transcription activator-like effector nucleases , to produce pigs with severe combined immunodeficiency by developing targeted modifications of the recombination activating gene 2 (RAG2).RAG2mutant pigs may become excellent animals to facilitate the development of xenotransplantation, regenerative medicine, and tumor biology. The use of pig biomedical models is vital for furthering the knowledge of, and for treating human, diseases.

Indexed as

CRISPR-Cas SystemsDeoxyribonucleasesGenetic EngineeringAnimalsBiomedical ResearchDNA-Binding ProteinsHumansModels, AnimalNuclear ProteinsSwineDeoxyribonucleasesDNA-Binding ProteinsNuclear ProteinsRAG2 protein, humanCRISPRmeganucleasespig modelstranscription activator–like effector nucleaseszinc finger nucleaseszygote injections

Identifiers

PMID26516165
PMCPMC4805444
OpenAlexW2197621574

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.